The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily
Open accessAbstract
Molecular events that result in loss of pain perception are poorly understood in diabetic neuropathy. Our results show that the receptor for advanced glycation end products (RAGE), a receptor associated with sustained NF-kappaB activation in the diabetic microenvironment, has a central role in sensory neuronal dysfunction. In sural nerve biopsies, ligands of RAGE, the receptor itself, activated NF-kappaBp65, and IL-6 colocalized in the microvasculature of patients with diabetic neuropathy. Activation of NF-kappaB and NF-kappaB-dependent gene expression was upregulated in peripheral nerves of diabetic mice, induced by advanced glycation end products, and prevented by RAGE blockade. NF-kappaB activation was blunted in RAGE-null (RAGE(-/-)) mice compared with robust enhancement in strain-matched controls, even 6 months after diabetes induction. Loss of pain perception, indicative of long-standing diabetic neuropathy, was reversed in WT mice treated with soluble RAGE. Most importantly, loss of pain perception was largely prevented in RAGE(-/-) mice, although they were not protected from diabetes-induced loss of PGP9.5-positive plantar nerve fibers. These data demonstrate, for the first time to our knowledge, that the RAGE-NF-kappaB axis operates in diabetic neuropathy, by mediating functional sensory deficits, and that its inhibition may provide new therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Self-citationNF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869
Self-citationDiabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Schleicher, E. D., Wagner, E., & Nerlich, A. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119180 · Cited by 714
Self-citationLi, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525
Self-citationLiliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
Self-citationVinik, A. I., Park, T. S., Stansberry, K. B., & Pittenger, G. L. (2000) · Diabetologia · doi:10.1007/s001250051477 · Cited by 489
Isolectin B4-Positive and -Negative Nociceptors Are Functionally Distinct
Stucky, C. L., & Lewin, G. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06497.1999 · Cited by 465
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Self-citationZiegler, D., Hanefeld, M., Ruhnau, K. J., Hasche, H., Lobisch, M., Schütte, K., Kerum, G., & Malessa, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1296 · Cited by 432
Nagamatsu, M., Nickander, K. K., Schmelzer, J. D., Raya, A., Wittrock, D. A., Tritschler, H., & Low, P. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1160 · Cited by 378
Self-citationBierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Müller, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1481 · Cited by 371
Self-citationOxidative Stress and Programmed Cell Death in Diabetic Neuropathy
VINCENT, A. M., BROWNLEE, M., & RUSSELL, J. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02108.x · Cited by 361
The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid
The SYDNEY Trial Authors, F. T. S. T. S. G., Ametov, A. S., Barinov, A., Dyck, P. J., Hermann, R., Kozlova, N., Litchy, W. J., Low, P. A., Nehrdich, D., Novosadova, M., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.770 · Cited by 359
Self-citationHereditary motor and sensory neuropathies.
Vance, J. M. (1991) · Journal of Medical Genetics · doi:10.1136/jmg.28.1.1 · Cited by 348
RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice
Arancio, O., Zhang, H. P., Chen, X., Lin, C., Trinchese, F., Puzzo, D., Liu, S., Hegde, A., Yan, S. F., Stern, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600415 · Cited by 328
Self-citationYeh, C.-H., Sturgis, L., Haidacher, J., Zhang, X.-N., Sherwood, S. J., Bjercke, R. J., Juhasz, O., Crow, M. T., Tilton, R. G., & Denner, L. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1495 · Cited by 326
Reversal of experimental diabetic neuropathy by VEGF gene transfer
Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12188 · Cited by 310
A role for ASIC3 in the modulation of high-intensity pain stimuli
Chen, C.-C., Zimmer, A., Sun, W.-H., Hall, J., Brownstein, M. J., & Zimmer, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122245999 · Cited by 308
Constien, R., Forde, A., Liliensiek, B., Gröne, H., Nawroth, P., Hämmerling, G., & Arnold, B. (2001) · genesis · doi:10.1002/gene.1030 · Cited by 294
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
American Diabetes Association, & American Academy of Neurology (1988) · Diabetes Care · doi:10.2337/diacare.11.7.592 · Cited by 286
Kislinger, T., Tanji, N., Wendt, T., Qu, W., Lu, Y., Ferran, L. J., Taguchi, A., Olson, K., Bucciarelli, L., Goova, M., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.905 · Cited by 285
Self-citationGlucose-induced oxidative stress and programmed cell death in diabetic neuropathy
Greene, D. A., Stevens, M. J., Obrosova, I., & Feldman, E. L. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00356-8 · Cited by 228
Okamoto, K., Martin, D. P., Schmelzer, J. D., Mitsui, Y., & Low, P. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7677 · Cited by 226
Lernbecher, T., Müller, U., & Wirth, T. (1993) · Nature · doi:10.1038/365767a0 · Cited by 224
Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.
Vlassara, H., Brownlee, M., & Cerami, A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5190 · Cited by 200
High Constitutive NF-κB Activity Mediates Resistance to Oxidative Stress in Neuronal Cells
Lezoualc’h, F., Sagara, Y., Holsboer, F., & Behl, C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03224.1998 · Cited by 187
Hofmann, M. A., Schiekofer, S., Isermann, B., Kanitz, M., Henkels, M., Joswig, M., Treusch, A., Morcos, M., Weiss, T., Borcea, V., et al. (1999) · Diabetologia · doi:10.1007/s001250051142 · Cited by 183
Self-citationSchiekofer, S., Andrassy, M., Chen, J., Rudofsky, G., Schneider, J., Wendt, T., Stefan, N., Humpert, P., Fritsche, A., Stumvoll, M., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.621 · Cited by 180
Self-citationMenéndez, L., Lastra, A., Hidalgo, A., & Baamonde, A. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00483-6 · Cited by 176
Sugimoto, K., Nishizawa, Y., Horiuchi, S., & Yagihashi, S. (1997) · Diabetologia · doi:10.1007/s001250050839 · Cited by 159
S‐100 proteins in the human peripheral nervous system
González‐Martínez, T., Pérez‐Piñera, P., Díaz‐Esnal, B., & Vega, J. A. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10304 · Cited by 157
C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat
Sima, A. A. F., Zhang, W., Sugimoto, K., Henry, D., Li, Z., Wahren, J., & Grunberger, G. (2001) · Diabetologia · doi:10.1007/s001250100570 · Cited by 151
Cameron, N. E., & Cotter, M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118104 · Cited by 147
Ahlgren, S. C., & Levine, J. D. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.2.684 · Cited by 122
Diabetic Neuropathy and the Microcirculation
Flynn, M. D., & Tooke, J. E. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00480.x · Cited by 116
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M. A., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Muller, M., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.9.1481 · Cited by 106
Self-citationHounsom, L., Horrobin, D. F., Tritschler, H., Corder, R., & Tomlinson, D. R. (1998) · Diabetologia · doi:10.1007/s001250050996 · Cited by 105
Self-citationNeurotrophins and peripheral neuropathy
Tomlinson, D. R., Fernyhough, P., & Diemel, L. T. (1996) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1996.0042 · Cited by 83
The elderly Type 2 diabetic patient: special considerations
Morley, J. E. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(1998120)15:4+<s57::aid-dia741>3.0.co;2-d · Cited by 73
Poduslo, J. F., & Curran, G. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2218 · Cited by 73
Small fiber neuropathy and neurovascular disturbances in diabetes mellitus
Vinik, A., Erbas, T. A., Stansberry, K., et al. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-18602 · Cited by 64
Nerve injury alters the effects of interleukin-6 on nociceptive transmission in peripheral afferents
Flatters, S. J. L., Fox, A. J., & Dickenson, A. H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.013 · Cited by 40
Haak, E., Usadel, K. H., Kohleisen, M., Yılmaz, A., Kusterer, K., & Haak, T. (1999) · Microvascular Research · doi:10.1006/mvre.1999.2151 · Cited by 39
Thrombomodulin Deficiency in Human Diabetic Nerve Microvasculature
Hafer‐Macko, C. E., Ivey, F. M., Gyure, K. A., Sorkin, J. D., & Macko, R. F. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1957 · Cited by 32
Research works printed but not linked: 7
- 10.1002/(SICI)1096-9136(1998120)15:4+<s57::aid-dia741>3.3.CO;2-4</s57::aid-dia741> · doi:10.1002/(sici)1096-9136(1998120)15:4+<s57::aid-dia741>3.3.co;2-4</s57::aid-dia741>
- Carrington, 1999, Diabetes Reviews., 7, 275
- 10.1016/S0006-8993(99)01670-4 · doi:10.1016/s0006-8993(99)01670-4
- 10.1007/s00401-002-0518-8 · doi:10.1007/s00401-002-0518-8
- Schmidt, 2001, J. Clin. Invest., 108, 949, 10.1172/JCI200114002 · DOI
- Liliensiek, 2004, J. Clin. Invest., 113, 1641, 10.1172/JCI200418704 · DOI
- Neundörfer, 1998, Dtsch. Med. Wochenschr., 23, 1519, 10.1055/s-2007-1023888 · doi:10.1055/s-2007-1023888
Cited by
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Self-citationDietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Ramasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F., & Schmidt, A. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi053 · Cited by 834
Self-citation
Metadata
- Authors
- Bierhaus, A., Haslbeck, K.-M., Humpert, P. M., Liliensiek, B., Dehmer, T., Morcos, M., Sayed, A. A. R., Andrassy, M., Schiekofer, S., Schneider, J. G., Schulz, J. B., Heuss, D., Neundörfer, B., Dierl, S., Huber, J., Tritschler, H., Schmidt, A.-M., Schwaninger, M., Haering, H.-U., Schleicher, E., Kasper, M., Stern, D. M., Arnold, B., & Nawroth, P. P.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-12-15
- Volume
- 114
- Issue
- 12
- Pages
- 1741-1751
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2162666481
- Cited by
- 299
- References
- 50
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.